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Abstract
Characteristics of a small-animal radiotherapy device, the X-RAD SmART, are described following commissioning of the 
device for pre-clinical radiotherapy research. Performance characteristics were assessed using published standards and com-
pared with previous results published for similar systems. Operational radiation safety was established. Device X-ray beam 
quality and output dose-rate were found to be consistent with those reported for similar devices. Output steadily declined over 
18 months though remained within tolerance levels. There is considerable variation in output factor across the international 
installations for the smallest field size (varying by more than 30% for 2.5 mm diameter fields). Measured depth dose and 
profile data was mostly consistent with that published, with some differences in penumbrae and generally reduced flatness. 
Target localisation is achieved with an imaging panel and with automatic corrections for panel flex and device mechanical 
instability, targeting within 0.2 mm is achievable. The small-animal image-guided radiotherapy platform has been imple-
mented and assessed and found to perform as specified. The combination of kV energy and high spatial precision make it 
suitable for replicating clinical dose distributions at the small-animal scale, though dosimetric uncertainties for the narrowest 
fields need to be acknowledged.
Keywords Small animal radiotherapy · Pre-clinical · Commissioning · Dose delivery · Image guidance
Introduction
It is problematic to evaluate alterations to radiotherapy treat-
ments, including in combination with new drugs, on human 
populations. Problems include unknown or unexpected 
interactions and adverse effects, the lengthy and complex 
clinical trial process, ethics issues, the large number of sub-
jects required to achieve statistical significance for an inter-
vention presenting clinical equipoise, and the difficulties 
of undertaking detailed post-treatment anatomical studies. 
Pre-clinical studies can be undertaken on small animals to 
mitigate these difficulties, with devices for delivering high-
precision radiotherapy treatments on small animals now 
commercially available. These devices attempt to mimic 
the dose deliveries achievable with clinical units and are 
considered a major step in radiobiology research [1].
Over the last two decades, significant advances in radio-
therapy technology have enabled increasingly sophisticated 
methods for treatment planning, delivery and imaging to 
be implemented into routine radiation oncology practice 
[2–4]. Several groups have developed small animal (3D) 
image-guided radiotherapy devices, which similarly allow 
precise irradiation of structures in small animals [2, 5, 6], 
thus bridging the gap between preclinical and clinical radi-
otherapy technology. However, the commissioning of kV 
small field devices is lacking published data [4].
Verhaegen et al. highlighted the efforts of five research 
groups and compared the characteristics of their developed 
systems [6]. The photon energy investigated ranged between 
5 and 380 keV, with field sizes ranging from 0.5 mm to 
20 mm diameter. Most institutions could use fixed fields 
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as well as arcs for the irradiation. Targeting accuracy var-
ied from 0.065 mm to 0.2 mm. Recommendations were 
made for the ideal requirements for an image-guided small 
animal irradiator which included a targeting accuracy of 
± 0.1–0.3 mm depending on the type (size) of animal treated.
The aim of this study was to report on the commission-
ing and performance characteristics of the first dedicated 
pre-clinical image-guided radiotherapy (IGRT) system in 
Australasia. This study followed acquisition of a commercial 
small-animal IGRT system, the X-RAD SmART (Precision 
X-ray, North Bramford CT), at the Telethon Kids Institute 
in Perth, Western Australia. Newton et al. commissioned the 
same device incorporating point, 2D and 3D measurements 
and concluded independent 2D and 3D measurements to be 
valuable to ensure accurate and comprehensive commission-
ing [7]. Lindsay et al. [8] previously compared the dosimet-
ric and geometric properties of X-RAD devices installed 
at three institutions. The commissioning procedure defined 
by Lindsay et al. was replicated in the present study and, 
where possible, measurement results were compared with 
those from Lindsay et al. and other published data. This 
provides some perspective on the operating characteristics of 
these devices, the variability of those characteristics between 
devices and the likely uncertainties in reported experimental 
parameters.
Materials and methods
Pre‑clinical IGRT system
The X-RAD has a dual focal-spot X-ray tube mounted on a 
rotating gantry at a source-to-isocentre distance of 306.4 mm, 
as can be seen in Fig. 1. Gantry angles are defined with 0° 
corresponding to the source at the top of rotation through to 
+ 360° over clockwise rotation when facing the gantry axis. 
X-ray energies up to 225 kVp can be generated with either 
0.3 mm Cu or 2 mm Al filters (typically used for therapy and 
imaging, respectively), with manually attached collimators 
defining 2.5, 5, 10 and 25 mm diameter circular fields and 
10 × 10 mm2 and 40 × 40 mm2 square fields (dimensions at 
isocentre). A Perkin Elmer amorphous silicon imaging panel 
is mounted on the counter side of the gantry and is used 
for image-based localization using cone-beam computed 
tomography (CBCT) or planar imaging as well as for veri-
fying beam targeting (resolution ~ 0.1 mm at isocentre). A 
remotely-controlled platform allows for positioning of the 
animal relative to the beam. Beam delivery can be performed 
by either static beams or arc rotation. The system sits in a 
fully self-shielded cabinet. The system installed at the Tel-
ethon Kids Institute has an optical camera installed orthogo-
nal to the X-ray beamline for bioluminescence studies. The 
X-RAD SmART is controlled by Pilot software version 1.12.
Treatment planning is achieved with SmART-Plan version 
1.3.12 installed on a Dell Precision Tower 5810 running on 
Ubuntu 12.04.1 LTS 64 bit. This system allows manual design 
of beams with a Monte Carlo dose calculation performed 
on cone-beam CT images acquired using the Perkin Elmer 
panel. The Monte Carlo algorithm utilises pre-calculated 
phase space files, for each collimator, provided by the manu-
facturer. Absolute calibration of the dose calculation is made 
by matching calculated dose output to the device absolute 
output measurement. This can require applying some output 
corrections, especially for the smallest collimators, to account 
for the effect of slight misalignment of the X-ray source and 
collimator. For the Telethon Kids Institute unit, a correction 
of 0.93 was applied for just the 2.5 mm diameter collimator.
Radiation survey
A radiation survey was undertaken around the cabinet to test 
for leakage. The device was operated with the typical therapy 
settings (225 kV, 0.2 mm Cu filter at 13 mA) with the gantry 
at 0°, 180°, 225°, 270°, 315°. A calibrated, pressurised µR 
ion chamber survey meter (Fluke 451, s/n 451P-DE-SI-RYR, 
Fluke Biomedical, Cleveland OH) was used for obtaining 
the dose rates at 11 points external to the device cabinet as 
shown in Fig. 2. The highest rate was found on the side of the 
cabinet in alignment with the X-ray tube cathode–anode axis, 
and as such point 11 rotates with the gantry.
Absolute dosimetry
Half value layer (HVL)
HVL measurements were made with the gantry at 180° with 
an IBA FC65-G (3502) chamber (IBA Dosimetry GmbH, 
Schwarzenbuck, Germany), connected to a Sun Nuclear 
1014000-1Z PC electrometer (Sun Nuclear, Melbourne 
FL), positioned with its long axis at the gantry rotation axis. 
HVL was measured for 225 kV, 13 mA, large focal spot and 
using the Cu (treatment) filter by adding sheets of Cu (99.9% 
Fig. 1  X-RAD device components
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purity) to the beam exit window. The first and second HVLs 
were measured.
Output dose‑rate
Primary measurement of the output dose-rate for the device 
was according to the protocol defined by American Asso-
ciation of Physicists in Medicine (AAPM) Task Group 61 
(TG-61) protocol for 40–300 kV X-ray dosimetry [9]. Meas-
urement was made with a PTW TN30013 Farmer-type ion 
chamber in air.
Some modifications had to be made to the AAPM TG-61 
protocol, due to the difference in dimensions and accessibil-
ity compared to a clinical machine. The square 40 × 40 mm2 
field was used instead of the recommended 10 × 10 cm2 field. 
Calibration was also performed at a source to detector dis-
tance of 306.4 mm rather than the prescribed 100 cm due 
to the confines of the cabinet. Chamber positioning was 
achieved using the CBCT imaging facility.
Following calibration, a constancy measurement was 
made in-air using the FC65-G (3502) chamber and PC elec-
trometer. This chamber was used for all subsequent measure-
ments. Output constancy was then assessed at subsequent 
routine QA sessions occurring approximately bi-monthly.
Linearity
To investigate the output dose-rate linearity with current 
and time, in-air measurements were taken at the following 
settings: 225 kVp, Cu filter, at 1, 2, 5, 10, 30 and 60 s and 
13, 10, 8, 6, 4, 2, 1, 0.5, 0.2, 0.1 mA. The same ion cham-
ber, electrometer combination as described above was used, 
with the chamber positioned with its long axis on isocentre. 
The data was recorded and two curves were fitted: charge 
vs beam-on time and charge vs current. From the charge 
vs beam-on time graph the timer error (also known as the 
end-effect) was assessed. This was achieved by extrapolating 
the linear fit of the measured points and observing at which 
value it crossed the y-axis.
Relative dosimetry
Film dosimetry
For the characterisation and verification of dose distribu-
tions, radiochromic film (RCF) was used because of its 2D 
high-resolution dosimetric capabilities. The Gafrochromic 
EBT3 (Ashland Advanced Materials, Bridgewater NJ) 
film was used. In order to define a quantitative relationship 
between the optical density of the film and the dose deliv-
ered, a calibration curve was established. Pieces of the same 
badge of film used for the experiment later were placed at 
isocentre perpendicular to the beam and irradiated for vari-
ous beam-on times. From this, after adjusting for the meas-
ured output of the day, the incident dose (in Gy) was found.
In order to find a quantitative relationship between 
the optical density and the dose delivered, a calibration 
curve was established. The settings of the X-RAD for the 
calibration were 225 kV, 13 mA, large spot size with the 
40 × 40 mm2 collimator and the therapy filter (Cu). Pieces of 
film of approximately 4.5 × 3 cm2 were placed at the isocen-
tre perpendicular to the beam on the surface of a 5 cm thick-
ness of solid water slabs (RW3, IBA Dosimetry, Schwarzen-
ruck, Germany). The tendency for RW3 to underestimate 
percentage dose at depth [1] is acknowledged. Specific 
details of solid water used were not provided in the report by 
Lindsay et al. [8]. Irradiation at gantry 0° was performed for 
various beam-on times and associated calculated doses. For 
each dose, three films were irradiated to assess uncertainty.
The films were scanned into Sun Nuclear SNC Patient 
software (Sun Nuclear, Melbourne FL) 24 h after exposure 
using an Epson 10000 × l scanner with transparency unit. 
SNC Patient requires a scan setting of 48 bit and 75 dpi 
(being the clinical standard set up), with all colour correc-
tions turned off. The same batch of RCF was used for all 
measurements and was handled according to the recommen-
dations outlined in the AAPM TG-55 report [10]. The result-
ing images were then analysed in MATLAB for red, blue 
and green channels and a curve was fitted to the red channel 
response. The resulting relationship between intensity of the 
film and dose was used to process all other measurements.
Fig. 2  The location of the 11 survey points investigated during radia-
tion safety survey. Point 11 remained aligned with the X-ray tube 
cathode–anode axis (gantry angle indicated)
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The relative dosimetry measurements were made using 
EBT3 Gafchromic film in a solid water phantom, unless 
stated otherwise. The phantom consisted of solid water slabs 
with 1 cm and 0.5 cm thickness, positioned on the detector 
plate. EBT3 film was cut into approximately 5 × 5 cm2 pieces 
and inserted in between the slabs starting at the surface, 
from at 5 mm depth and then every 1 cm until a maximum 
depth of 5.5 cm was reached. The set-up was such that the 
surface of the solid water was at the isocentre of the device. 
The phantom was then irradiated for 120 s for every col-
limator. Seven films were evaluated per irradiation and the 
process was repeated three times for each collimator. All 
measurements were performed with the film being perpen-
dicular to the beam axis. The repeat measurements allow 
for the determination of measurement standard deviation, 
with uncertainties resulting from stochastic output changes, 
as well as inherent differences in the film, scanner and han-
dling, even though care was taken to keep these to a mini-
mum by following the standard practices when handling the 
RCF.
The irradiated films were subsequently scanned 24 h after 
exposure, and imported into MATLAB as TIFF images. In 
the processing and analysis of the images, adaptive filtering 
was performed to reduce the noise. This was done using the 
wiener2 function in MATLAB, which uses a pixel- wise 
adaptive Wiener method based on statistics estimated from 
a local neighbourhood of each pixel. Neighbourhoods of size 
[5] were used. Depending on the beam property investigated, 
either a region of interest was chosen from the films or the 
central values from which dose profiles could be extracted.
Percentage depth dose (PDD)
To calculate the PDD, the central ROI signal at 0 cm solid 
water depth was extracted from the corresponding films, 
averaged and taken as the reference. The ROI values of all 
other depths were obtained in the same manner and then 
compared to the reference to obtain the PDD (for each 
collimator).
Relative output factor (ROF)
The relative output factor was measured at a depth of 0.5 cm. 
The reference field for the relative output factor measure-
ment was 40 × 40 mm2 field. The ROF’s were calculated 
from:
where  Dcol and  Dref are the dose with a given collimator 
and the dose at the reference collimator respectively (both 
at solid water depth of 0.5 cm). To calculate the ROF the 
(1)ROFcol =
Dcol
Dref
central region of interest values of the TIFF images were 
used as defined by Lindsay et al.
Dose profiles
The profiles were taken through the central values in the x 
and y direction (cross-plane and in-plane) of the field. Each 
profile is the average of five adjacent profiles to provide bet-
ter statistics. From these profiles, symmetry, field size at 
full width half maximum (FWHM) and the penumbra were 
obtained for all available field sizes. The field size is defined 
by the region of 50% or more of the signal, normalised to 
the signal on central axis (the FWHM). Each penumbra was 
evaluated as the distance between the 80 and 20% of the 
signal.
Symmetry and flatness were both assessed within the 
central 80% of the field, a region bounded by 80% of the 
full field width. Symmetry of the profile is defined as the 
maximum value of the ratio of  D−x to  D+x:
D−x represents the signal at a distance x to one side of the 
central axis of the beam and  D+x is the signal at the cor-
responding point on the other side. Where, + x and − x are 
symmetric pixels starting closes to and then making their 
way further away from the central pixel.
For the flatness, the same field as for the symmetry is 
considered and the following is investigated:
where  Dmax and  Dmin are the maximum and minimum dose 
respectively of the central 80% profile as defined above.
The offset of the source from isocentre can be obtained 
using the beam penumbra in the in-plane and cross-plane 
direction. By subtracting the left from the right penumbra 
in both planes and then plotting the resulting values on a 
2D coordinate system, any systematic shift will be visible. 
This shift is coupled to any limits in tolerance in physical 
construction of the collimation system, and so is referred to 
here as an “effective offset”.
Inverse square law
The dose fall-off with distance should follow the inverse 
square law if the X-ray source represents a point. Due to 
additional source components, such as scatter from the cabi-
net walls, the inverse-square behaviour may be disrupted. 
To determine the extent of this effect, the ion chamber was 
fixed at isocentre and then irradiated three times at 225 kVp, 
13 mA using the 40 × 40 mm2 collimator and an average 
was taken. This was repeated at + 5 cm, + 3 cm, − 3 cm 
(2)Symmetry = max||D+x − D−x|| ∗ 100%
(3)Flatness =
Dmax − Dmin
Dmax + Dmin
∗ 100%
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and − 5 cm from isocentre by moving the couch vertically 
(y-direction) only. To calculate the effective SSD:
where  D0 is the dose at zero y offset of the couch, DΔ is the 
dose at a certain offset in y of Δ , and SSDeff  is the effective 
SSD. SSDeff  was found by obtaining linear fit to a plot of DΔ 
against Δ and applying Eq. 4.
Simulation of solid water with planning system
In order to simulate dose delivery in the solid water slabs 
using the Monte Carlo software and compare planned versus 
delivered distributions, a digital solid water phantom was 
made (RW3—7.59% H, 90.41% C, 0.8% O, 1.2% Ti; 1.06 
g cm−3) and imported into the treatment planning program 
for the X-RAD (SmART-Plan). Note that to ensure accurate 
simulation of scatter conditions, the simulated phantom had 
to replicate the physical dimensions of the physical phan-
tom. Dose calculation voxels were 0.25 mm wide in each 
dimension normal to the beam axis and 1 mm along the 
depth axis. The same exposures that were used for meas-
urements were simulated and the dose was exported into 
DICOM files. A Monte Carlo simulation dose calculation 
uncertainty (variance) of 1% to the highest dose voxel was 
specified. The DICOM files created were imported and ana-
lysed using MATLAB. The measurements for ROF, field 
size, penumbra, symmetry and flatness were obtained using 
the same methods as for the RCF data above. The results 
were obtained from slices at the same depths that were irra-
diated with the RCF.
The SmART-Plan system reports dose-to-medium and 
film was not included in the simulation. In comparison with 
relative dose values, an assumption is made that ratios of 
doses to the RW3 medium are equivalent to ratios of dose 
to film at the same points.
Mechanical operation and performance
The mechanical tests were conducted using a BB (ball bear-
ing) attached to a narrow Perspex rod. Positioning and move-
ment of the ball bearing relative to the beam and imaging 
axes is determined automatically using manufacturer-sup-
plied software, at the precision of individual image pixels 
(0.1 mm at isocentre).
Magnification
The Pilot software provides an automated process for assess-
ing magnification factor, source to axis distance (SAD) and 
source to (panel) detector distance (SDD). This process 
(4)
(
D0
DΔ
)2
= 1 +
Δ
SSDeff
utilises the BB attached to the remotely-controlled stage, 
imaged with the Perkin Elmer a-Si panel.
Panel flex
Assessment of flex of the imaging panel with gantry rotation 
is made by imaging the BB in multiple fixed positions during 
complete 360° gantry rotations. The resulting “projection” 
maps or “flexmaps” of the lateral (u) and longitudinal (v) 
flex of the panel were acquired for both the small and large 
focal spot sizes. The Pilot software stores measured flexmaps 
for correcting subsequent acquired images.
Isocentre stability
Changes in the device isocentre position and collimator 
alignment with gantry rotation were assessed using the 
“Winston-Lutz” calibration. A single BB was positioned at 
the machine isocentre and its position relative to the colli-
mator-defined beam during a full 360° gantry rotation was 
measured. The Pilot software generated the resulting (u, v) 
displacements required to ensure the BB remains at the cen-
tre of collimation. These displacements, and the flexmap 
calibration, were applied to a repeat Winston-Lutz calibra-
tion to assess the overall accuracy of target tracking during 
gantry rotation.
Results
Radiation Survey
The background radiation was measured to be 0.05 μSv/h. 
The surveyed dose rates are presented in Table 1. None of 
the values are significantly larger than background, except 
for adjacent to the cabinet in alignment with the X-ray tube 
cathode–anode axis.
Absolute dosimetry
The 1st and 2nd HVL were found to be 1.05 mm Cu and 
2.06 mm Cu respectively with an estimated 2% uncertainty 
(compared to values of 0.98, 0.91, 1.02, and 1.95, 1.89 and 
2.14 respectively for the three centres reported by Lind-
say et al.). The results for the absolute output are shown in 
Table 2. The results for the output constancy over time are 
presented in Fig. 3.
The values obtained for dose linearity at different currents 
from 0.1 to 13 mA are presented in Fig. 4. From these the 
time error can be obtained as 0.116 s, which occurs at the 
smallest current of 0.1 mA with a linear fit of  R2 = 0.981.
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Relative dosimetry
The uncertainty indicated in results is the standard devia-
tion between the three films evaluated for each irradiation. 
Figure 5 shows the PDD curves for all collimators. PDD 
values from the SmART-Plan calculation (not presented) are 
within 3% PDD of measurement at all depths.
The results for the ROF measurements are presented in 
Fig. 6 for different field sizes relative to the 40 × 40 mm2 
field, measured at 5 mm depth of solid water. Additionally, 
the values from Lindsay et al. [8] as well as Jeong et al. [11]. 
and those calculated in the planning system (SmartPlan) are 
presented for comparison.
A summary of all beam profile characteristics obtained 
from the profiles is presented in Table 3, compared with 
calculated profiles from SmART-Plan and those published.
The graph obtained for the effective offset of the X-ray 
source from isocentre in both planes is presented in Fig. 7.
For distances within 5 cm of the isocentre the effective 
SSD measured was 30.2 cm with  R2 = 0.999.
Mechanical operation and performance
The magnification measurement indicated an SAD of 
30.6 ± 0.1 cm, SDD to the imaging panel of 62.5 ± 0.1 cm 
resulting in a magnification factor of 2.04. The obtained flex 
maps are shown in Fig. 8 for the big (red line) and small 
Table 1  Dose rate (μSv/h)—background dose rate 0.05 μSv/h at the 
surveyed points minus background radiation, for five different gantry 
angles (G)
G = 0° means the X-ray source is irradiating vertically downwards. 
G = 270° means the X-ray source is irradiating the doors front on. 
Measurement error in each case is 0.01 μSv/h
Point G = 0° G = 315° G = 270° G = 225° G = 180°
1 0.13 0.10 0.14 0.08 0.10
2 0.10 0.08 0.13 0.05 0.10
3 0.03 0.10 0.05 0.07 0.08
4 0.08 0.06 0.08 0.06 0.08
5 0.00 0.05 0.01 0.06 0.02
6 0.09 0.05 0.06 0.03 0.02
7 0.06 0.04 0.09 0.09 0.11
8 0.08 0.15 0.12 0.06 0.13
9 0.05 0.09 0.06 0.09 0.06
10 0.21 0.15 0.12 0.07 0.10
11 0.81 0.86 0.83 0.70 0.25
Table 2  Absolute output in 
air and in phantom for the 
40 × 40 mm2 collimator at the 
system isocentre
The values from Lindsay et al. [8] are the means (± SD) from three institutions
40 × 40 mm2 collimator Lindsay et al. Difference (%)
Output in air (Gy/min) 3.61 ± 0.05 3.67 ± 0.21 1.64
Output in phantom (Gy/min) 3.07 ± 0.05 3.17 ± 0.21 3.16
PDD at 2 cm depth (%) 75.00 ± 3.00 77.00 ± 2.00 2.60
TPR at 2 cm depth (%) 85.13 ± 3.00 87.67 ± 0.03 2.90
Phantom/air output (%) 85.14 ± 0.10 87.00 ± 0.01 2.14
Fig. 3  Output constancy with 
time at 225 kV, 13 mA. Error 
bars represent an estimated 
combined (baseline and con-
stancy measurement) uncer-
tainty of ± 1%
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(blue line) focal spot. The values are shown relative to the 
system isocentre.
The results for the Winston-Lutz (W-L) test for u and v 
of the system with tracking off and on are shown in Fig. 9.
The magnitude of the flex in both u and v (with tracking 
off) has a maximum of 2.02 mm. The maximum residual 
motion (after W-L test with tracking on) in (u, v) is (0.2, 
0.1) mm.
Discussion
The results from this study indicate the performance charac-
teristics of the X-RAD device installed at the TKI. Compari-
son with similar results published for devices from the same 
manufacturer provide indication of the variability likely in 
reports of experiments undertaken on such devices installed 
globally. The estimated uncertainties and variability in dose 
delivery has been poorly reported in small-animal studies 
[12]. The measurements performed and quantities pre-
sented here are intended to be comparable with the reporting 
requirements detailed in Desrosiers et al. [12].
Absolute dosimetry
The absolute output dose-rate measured for the Telethon 
Kids Institute’s X-RAD device is consistent with those 
reported across other institutions by Lindsay et al. [8]. The 
beam quality, assessed with HVL, PDD and TPR, is also 
consistent across institutions, varying within acceptable 
uncertainties.
The output constancy presented in Fig. 3 showed some 
consistent decline over the 18 months of monitoring though 
has remained within the established tolerance, which is < 2% 
for two consecutive readings or < 3% for a single reading. 
Note that international standards for dosimetric traceability 
and uncertainty in pre-clinical IGRT systems have not yet 
been established and these tolerances have been arbitrarily 
selected. A recent survey of small-animal irradiators [13] 
indicated variations of 5% to 42% in expected dose delivery.
The time error of 0.116 s for the system investigated is 
consistent with those reported for the systems studied by 
Lindsay et al. [8] being less than 0.2 s and varying in sign 
and magnitude across the range of beam currents. Timer 
error was ignored in timer calculations.
Relative dosimetry
The measured PDD data in Fig. 5 display expected char-
acteristics for a 225 kVp beam, with scatter contributions 
increasing with increasing exposed beam area. Although not 
shown, measured depth-dose data was consistent with those 
calculated via the phantom simulation in SmART-Plan.
Fig. 4  Linearity curve: charge versus beam-on time for multiple beam 
currents
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548 Australasian Physical & Engineering Sciences in Medicine (2019) 42:541–551
1 3
Table 3  Relative dosimetry 
results x and y direction 
averaged, measured at 5 mm 
depth in solid water phantom
The values from the film are presented against the values from Lindsay et al. [8], as well as calculated in 
the SmART-Plan TPS (interpolated from the dose grid). Differences in % are relative to the film measure-
ments, being absolute change in symmetry and flatness. Symmetry values from the TPS only reflect calcu-
lation variance and are not indicated
Average SD Lindsay et al. SD Diff. (%) TPS Diff. (%)
2.5 mm
 Field size (mm) 2.64 0.06 2.53 0.28 4.1 2.25 14.8
 Penumbra (mm) 1.06 0.02 0.53 0.19 49.8 0.64 39.8
 Symmetry 6.23 0.79 – – – – –
 Flatness 5.27 0.32 – – – 21.09 300.3
5 mm
 Field size (mm) 5.30 0.02 5.53 1.07 4.4 4.99 5.8
 Penumbra (mm) 1.12 0.06 0.57 0.12 49.6 0.61 45.7
 Symmetry 1.92 0.28 0.67 0.24 65.3 – –
 Flatness 5.41 0.21 4.83 3.32 10.7 22.79 320.9
10 mm
 Field size (mm) 10.34 0.00 10.00 0.34 3.3 10.23 1.1
 Penumbra (mm) 1.01 0.05 0.57 0.15 44.0 0.60 40.7
 Symmetry 1.05 0.45 2.03 1.48 94.3 – –
 Flatness 5.94 0.50 2.10 0.57 64.6 12.44 109.4
10 × 10 mm2
 Field size (mm) 10.44 0.02 10.27 0.12 1.7 10.36 0.8
 Penumbra (mm) 1.08 0.06 0.63 0.08 41.5 0.61 43.6
 Symmetry 1.76 0.59 1.07 1.01 39.2 – –
 Flatness 6.19 0.40 1.70 0.14 72.5 10.00 61.6
40 × 40 mm2
 Field size (mm) 39.53 0.38 41.50 2.63 5.0 42.08 6.4
 Penumbra (mm) 1.44 0.15 1.43 0.90 0.2 0.84 41.5
 Symmetry 0.21 0.01 3.93 2.14 1733.4 – –
 Flatness 5.46 0.31 4.73 0.68 13.3 14.66 168.5
Fig. 7  Effective offset of the 
source from isocentre in the x 
and y plane
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As can be seen in Fig. 6, there is considerable variation 
in output factor across the reported and measured values, 
with large variations in measured ROF for the smallest col-
limator. This effect also translates to a comparison of the 
measured and calculated ROFs for the Telethon Kids Insti-
tute’s X-RAD system, which, although within 3% for the 
other field sizes, is approaching a difference of 30% for the 
2.5 mm circular collimator. This variation within a centre 
and between centres presents some considerable concern 
for dose delivery and reporting for experiments involving 
that smallest field size. Several factors could influence that 
consistency, including volume-averaging and uncertainties 
in the dose calculation (noting that in Fig. 7, error bars in the 
SmART-Plan values indicate standard deviation in the dose 
calculation), sensitivity to alignment of the X-ray focal spot 
and collimation system and focal spot shape, and discrepan-
cies in collimator manufacture that are not accommodated 
by the planning system [8].
As presented in the quantified profile information in 
Table 3, field sizes differ from the average published 
values by 5% or less, however other measured dose pro-
file quantities vary more widely. Penumbral widths dif-
fer considerably, though in absolute terms they vary 
between devices by less than 0.7 mm, and more consist-
ently between the film measurements and SmART-Plan. 
It should be noted that the penumbral width measurement 
was sensitive to noise along the profile. The discrepan-
cies could also be due to resolution difference; the use of 
75 dpi scanning was a limitation for accurate penumbra 
assessment for such small fields, and higher resolution 
scanning is recommended in future studies. Differences 
between measured and published profile quantities become 
smaller for larger field sizes. For the 40 × 40 mm2 colli-
mator, there is also considerable variability in penumbral 
measurements across the devices reported by Lindsay et al. 
Flatness was reduced (beam profiles were less flat) in the 
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Fig. 8  a Flex map in the u-axis (orthogonal to the axis of rotation). b Flex map in the v-axis (parallel to the axis of rotation of the system)
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device relative to those reported for profiles by Lindsay 
et al., and SmART-Plan calculated values typically outside 
the uncertainty in measured values. Also, in comparing 
values in Table 3 it is assumed that interpretation of the 
derived quantities and their calculation are consistent with 
those by Lindsay et al.
Consistency in the field width and penumbral size was 
generally found between the x and y directions, though posi-
tions of the effective source offset for all collimators are 
grouped in the same quarter of the coordinate system as can 
be seen in Fig. 7. This is indicative of a systematic shift in 
the x-ray source from isocentre to the right in the in-plane 
and cross-plane directions.
The obtained value for the effective SSD at isocentre of 
30.2 cm is slightly higher than the values found by Lindsay 
et al. The value is consistent with the measured SAD of 
30.6 cm, given the presence of additional scatter sources.
Mechanical operation and performance
The manufacturer specified an SAD of 30.64 cm, consist-
ent with the value of 30.6 ± 0.1 cm for the Telethon Kids 
Institute’s X-RAD system. Lindsay et  al. found values 
consistently between 30.1 cm and 30.2 cm for SAD and 
62.0 cm and 62.3 cm and suggested that such consistency 
means standard values could be used across their systems. 
However, the sensitivity of image reconstruction to SAD 
and the 4 to 6 mm difference between their reported values 
and the Telethon Kids Insitute’s X-RAD system indicates 
that SAD and SSD need to be established at each institution 
independently.
The values obtained for gantry flex (Fig. 8) are consistent 
with those presented by Lindsay et al. Gantry flex measure-
ments must be undertaken independently on each system 
as the image reconstruction algorithm uses the flex data to 
correct acquired planar images. In addition, the mechanical 
variations in isocentre with gantry rotation, quantified via 
Winston-Lutz test (Fig. 9) and showing oscillations of the 
order of 2 mm lateral to the beam axis, are automatically 
compensated for via movement (tracking) of the animal sup-
port stage. As such, with the tracking applied according to 
the isocentre pattern of Fig. 9a, the movement is reduced 
to < 0.2 mm as shown in Fig. 9b (within the resolution of 
the imaging system ~ 0.1 mm).
Conclusion
This study enabled characterisation of a commercially 
available small-animal IGRT system and a comparison 
of its performance characteristics with similar devices. 
Basic dosimetric quantities are comparable between the 
system studied here and those reported elsewhere, with a 
notable exception being the output dose-rate for the small-
est collimator (2.5 mm circular) where variation between 
systems from the same manufacturer have already been 
demonstrated. In addition, a large difference was found 
between expected and delivered dose for this collima-
tor indicating that experiments utilising that collimator 
should consider the importance of accurate dose delivery 
and subsequent reporting of that delivery. By virtue of 
the automatic motion-compensation process incorporated 
into the X-RAD design, beam targeting accuracy through-
out the gantry rotation can be achieved to within 0.2 mm. 
The device was considered acceptable for its intended 
purpose, though limitations of dosimetric and geometric 
accuracy are being considered during design of relevant 
experiments.
Although commissioning of the small-animal IGRT 
device mimicked aspects of commissioning of a comparable 
clinical IGRT system, physical restrictions on the design of 
the device, significantly different beam quality and dimen-
sions, and higher spatial resolution mean some measure-
ments and procedures needed to be customised. As these 
systems become more widely used, it is important that their 
dosimetric calibration and characterisation is consistently 
performed and reported so that subsequent small-animal 
experiments can be undertaken and stated with a similar 
level of consistency and comprehensiveness as clinical treat-
ments. This study can hopefully form a part of the move to 
such consistency.
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